| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Executive Chairman | Non-executive Chairman
3 companies
Gabriele M Cerrone is Director, 10% Owner at TLSA and has filed Form 4s across 3 companies. Gabriele M Cerrone's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $47.5M at current prices.
The biggest single holding is TLSA (~$30.9M) as Director, 10% Owner.
Gabriele M Cerrone has 20 Form 4 filings on record from April 2022 to July 2026, across 3 companies: Director, 10% Owner at OKYO Pharma (OKYO), 2022–2026; Director, 10% Owner at Tiziana Life Sciences (TLSA), 2026; Director, 10% Owner at Accustem Sciences (ACUT), 2022–2025.
The 27 reported transactions were 20 open-market purchases, 5 stock awards and 2 other transactions.
Counted by filing, the open-market trades come to 14 purchases worth about $919K and no sales.
The largest open-market purchase was 5,800,000 shares of OKYO at an average $0.08 on May 19, 2022, about $441K. Twelve months later OKYO was down 53%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | ACUT Accustem Sciences Inc. | Director, 10% Owner | Buy | 2,400 | $1.02 | $2,440.00 | - | |
| Jun 12, 2025 | ACUT Accustem Sciences Inc. | Director, 10% Owner | Buy | 37,196 | $0.50 | $18,462.48 | +0.6% | |
| Apr 9, 2025 | ACUT Accustem Sciences Inc. | Director, 10% Owner | Buy | 38,000 | $0.67 | $25,285.00 | +0.8% | |
| Apr 7, 2025 | ACUT Accustem Sciences Inc. | Director, 10% Owner | Buy | 152,802 | $0.51 | $78,291.42 | +3.2% | |
| Dec 31, 2024 | ACUT Accustem Sciences Inc. | Director, 10% Owner | Buy | 100,000 | $0.38 | $38,100.00 | +2.2% | |
| Dec 30, 2022 | ACUT Accustem Sciences Inc. | Director, 10% Owner | Buy | 5,000 | $1.40 | $7,000.00 | +0.1% | |
| Dec 2, 2022 | ACUT Accustem Sciences Inc. | Director, 10% Owner | Buy | 3,729 | $1.42 | $5,295.18 | - | |
| Nov 18, 2022 | ACUT Accustem Sciences Inc. | Director, 10% Owner | Buy | 24,500 | $1.05 | $25,725.00 | +0.6% | |
| Aug 1, 2022 | ACUT Accustem Sciences Inc. | Director, 10% Owner | Buy | 10,000 | $0.79 | $7,900.00 | +0.3% | |
| Jun 8, 2022 | ACUT Accustem Sciences Inc. | Director, 10% Owner | Buy | 20,000 | $0.50 | $10,000.00 | +0.5% |